$
0.000
0.000(0.000%)
  • Overview
  • Forecast
  • Valuation
High
133.570
Open
125.000
VWAP
128.04
Vol
73.77K
Mkt Cap
716.87M
Low
120.920
Amount
9.44M
EV/EBITDA(TTM)
6.70
Total Shares
49.72M
EV
1.05B
EV/OCF(TTM)
45.33
P/S(TTM)
1.17

Nutex Health Inc. is a healthcare management and operations company. The Company operates through two divisions: the Hospital division and Population Health Management division. The Hospital division owns and operates approximately 22 facilities in e...Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2025Q2
FY2025Q3
81.09M
+20.22%
--
--
84.58M
+11.17%
--
--
88.07M
+11.77%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Nutex Health Inc. (NUTX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 305.35%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+305.35%
In Past 3 Month
2 Analyst Rating
down Image
-49.06% Downside
Wall Street analysts forecast NUTX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUTX is 67.50 USD with a low forecast of 60.00 USD and a high forecast of 75.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
down Image
-49.06% Downside
Current: 132.507
sliders
Low
60.00
Averages
67.50
High
75.00
Maxim Group
Anthony Vendetti
Strong Buy
Maintains
$75 → $100
2025-04-08
Reason
Maxim raised the firm's price target on Nutex Health to $100 from $75 and keeps a Buy rating on the shares. The company delivered significantly better-than-expected Q4 results, driven largely by the company's success in achieving improved reimbursement by advancing claims through the No Surprises Act's IDR - independent dispute resolution - process, the analyst tells investors in a research note. Beyond IDR activity, Nutex continues to advance its core growth strategy, with its hospitals expanding service lines to treat higher-acuity patients and to drive increased inpatient and observation visit volumes, the firm adds.
Maxim Group
Anthony Vendetti
Strong Buy
Maintains
$50 → $75
2025-02-13
Reason
Benchmark
Bill Sutherland
Strong Buy
Maintains
$45 → $60
2024-11-12
Reason
Benchmark analyst Bill Sutherland raised the firm's price target on Nutex Health to $60 from $45 and keeps a Buy rating on the shares after what the firm calls "another big beat from top to bottom," with revenue and AEBITDA growth of 26% and 974%, respectively. Initiatives to increase patient volumes with a focus on higher value services point to continued growth and margin expansion, the analyst tells investors.
Maxim Group
Anthony Vendetti
Strong Buy
Maintains
$45 → $50
2024-11-12
Reason
Maxim raised the firm's price target on Nutex Health to $50 from $45 and keeps a Buy rating on the shares. The company's Q3 results topped estimates, with positive trends in metrics fueling its growth, the analyst tells investors in a research note. Maxim adds that the firm expects Nutex to generate $8.9M in operating cash per quarter through 2025 and believes that the company has sufficient capital to maintain current operations, even though it may raise capital to accelerate new hospital openings.
Maxim Group
Anthony Vendetti
Strong Buy
Initiates
$45
2024-09-18
Reason
Benchmark
Bill Sutherland
Strong Buy
Maintains
$30 → $45
2024-08-21
Reason

Valuation Metrics

The current forward P/E ratio for Nutex Health Inc (NUTX.O) is 56.83, compared to its 5-year average forward P/E of -32.35. For a more detailed relative valuation and DCF analysis to assess Nutex Health Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-32.35
Current PE
56.83
Overvalued PE
72.35
Undervalued PE
-137.06

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
73.12
Current EV/EBITDA
8.18
Overvalued EV/EBITDA
190.05
Undervalued EV/EBITDA
-43.80

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.57
Current PS
1.38
Overvalued PS
11.46
Undervalued PS
-4.31

Financials

Annual
Quarterly
FY2024Q4
YoY :
+269.77%
257.62M
Total Revenue
FY2024Q4
YoY :
+2701.30%
114.20M
Operating Profit
FY2024Q4
YoY :
-460.75%
99.97M
Net Income after Tax
FY2024Q4
YoY :
-233.19%
9.39
EPS - Diluted
FY2024Q4
-341.78K
Free Cash Flow
FY2024Q4
YoY :
+189.83%
54.98
Gross Profit Margin - %
FY2024Q4
YoY :
-230.33%
4.34
FCF Margin - %
FY2024Q4
YoY :
-197.56%
38.81
Net Margin - %
FY2024Q4
16.40
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
81.8K
USD
Months
3-6
0
0.0
USD
Months
6-9
3
62.2K
USD
Months
0-12
5
61.2K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

NUTX News & Events

Events Timeline
2025-04-15 (ET)
News
2.0
04-14Benzinga
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
2.0
04-09Benzinga
Simply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On Wednesday
9.5
04-01Benzinga
Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
4.0
04-01NASDAQ.COM
Validea Joel Greenblatt Strategy Daily Upgrade Report - 4/8/2025
2.0
03-31Business Insider
Closing Bell Movers: PVH jumps 15% on earnings and guidance
9.5
03-31PRnewswire
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
9.5
03-27Newsfilter
NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
1.0
03-20Newsfilter
Nutex Health to Present at the EDPMA Solutions Summit 2025
9.5
03-17Newsfilter
NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
4.0
02-13Benzinga
Maxim Group Maintains Buy on Nutex Health, Raises Price Target to $75
7.0
02-05Newsfilter
Nutex Health Issues No Surprises Act (NSA) Arbitration Update
2.0
01-21Newsfilter
Nutex Health Hospitals Earn Multiple Community Honors and Awards in Q4
5.0
01-13Newsfilter
NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA
5.0
01-13PRnewswire
NUTEX HEALTH OPENS STARKEY RANCH ER & HOSPITAL, ITS FIRST HOSPITAL IN FLORIDA
1.0
01-06Newsfilter
NUTEX HEALTH TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
5.0
2024-11-18Newsfilter
NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN
5.0
2024-11-18PRnewswire
NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN
2.0
2024-11-01Newsfilter
NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL
2.0
2024-09-30PRnewswire
NUTEX HEALTH HOSPITALS WIN MULTIPLE AWARDS IN THE 3rd QUARTER OF 2024
4.0
2024-09-19NASDAQ.COM
Maxim Group Initiates Coverage of Nutex Health (NUTX) with Buy Recommendation

FAQ

arrow icon

What is Nutex Health Inc (NUTX) stock price today?

The current price of NUTX is 132.5075 USD — it has increased 2.19 % in the last trading day.

arrow icon

What is Nutex Health Inc (NUTX)'s business?

arrow icon

What is the price predicton of NUTX Stock?

arrow icon

What is Nutex Health Inc (NUTX)'s revenue for the last quarter?

arrow icon

What is Nutex Health Inc (NUTX)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Nutex Health Inc (NUTX)'s fundamentals?

arrow icon

How many employees does Nutex Health Inc (NUTX). have?

arrow icon

What is Nutex Health Inc (NUTX) market cap?